Trademark applications and grants for Cempra Pharmaceuticals Inc. Cempra Pharmaceuticals Inc has 10 trademark applications. The latest application filed is for "NEXSOLERA"
Patent Application | Date |
---|---|
Compositions and Methods for Treating Dry Eye Diseases 20210137961 - 16/602279 Fernandes; Prabhavathi | 2021-05-13 |
PARENTERAL FORMULATIONS FOR ADMINISTERING MACROLIDE ANTIBIOTICS 20190328759 - 16/205445 PEREIRA; David E. ;   et al. | 2019-10-31 |
PROCESS FOR THE PREPARATION OF MACROLIDE ANTIBACTERIAL AGENTS 20190241602 - 16/155939 PEREIRA; David Eugene ;   et al. | 2019-08-08 |
POWDER ORAL SUSPENSION FORMULATIONS OF ANTIBACTERIAL AGENTS 20190209530 - 16/130217 PEREIRA; David Eugene ;   et al. | 2019-07-11 |
PARENTERAL FORMULATIONS OF MACROLIDE ANTIBIOTICS 20190054059 - 15/918098 PEREIRA; David Eugene ;   et al. | 2019-02-21 |
NCAGE Code | 4D2L7 | CEMPRA PHARMACEUTICALS, INC. |
CAGE Code | 4D2L7 | CEMPRA PHARMACEUTICALS, INC. |
S.A.M. Registration | 4D2L7 [623713034] | CEMPRA PHARMACEUTICALS, INC. |
SEC | 0001352044 | CEMPRA PHARMACEUTICALS INC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.